25 Mar 2020
EUR 750 million
|Date of agreement:||25 Sep 2012|
|Amount in USD:||USD 90 million|
|Amount in EUR:||EUR 69.7 million|
|NACE sector / loan type:||Health and social work|
|Business area:||Industries and services|
The USD 90 million (EUR 70 million) loan has been provided for financing an R&D investment to improve the usage of its ventilation and anaesthesia products.
Getinge’s R&D activities in its Medical Systems division are aimed to develop products for improved clinical outcome and reduced complexity in use. Increased support for integration with other products, modern user interfaces and state of the art clinical functions are expected to improve healthcare productivity.
Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. It operates under the brands of ArjoHuntleigh, Getinge and Maquet. ArjoHuntleigh focuses on patient mobility and wound management solutions. Getinge provides solutions for infection control within healthcare and contamination prevention within life sciences. Maquet specialises in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.
Getinge’s past performance suggests that allocating more resources to R&D should contribute to the productivity and competitiveness of the company. The increase in Getinge’s R&D is likely to affect the productivity of other companies operating in the same industry or region through spill-overs, which could further contribute to knowledge creation and diffusion.
The environmental impact is perceived as neutral.